Replies to post #171529 on Amarin Corp Plc (AMRN)

[Biobillionair]

OK...I'm not for a buyout less than $75b...so we are not on the same page...next--BB

[ranjo]

let's get real amarin is not going it alone. They will sell or partner after it becomes clear they get or will get label expansion.. they need a sales team in the multiple thousands to adequately cover the PCP's, cardio and endo community and that is just for CV indications. DTC will be at a minimum 1 mil per week maybe twice that initially.. the opportunity costs of building out a sales team and R & D to expand indications because of the multifactorial effects is enormous. There is a way we get our cookie if negotiated correctly... buy with both fists